Skip to Content


R&D in Key Therapeutic Areas

Almirall scientists work on providing solutions in key therapeutic areas. They aim to bring new treatments to market in the field of dermatology, as well as having a significant stake in pain.

Our biologists and chemists apply the most advanced technologies to understand underlying disease mechanisms. With this knowledge, they design and synthesise safe and efficacious chemical entities that provide greater treatment options to healthcare professionals. Their efforts have resulted in medicines used by patients in over 70 countries.

Results of our Proprietary R&D

  • Aceclofenac
  • Aclidinium
  • Almagate
  • Almotriptan
  • Ebastine
  • Cinitapride
  • Clebopride
  • Piketoprofen

Almirall invested 12,8% of its net income in R&D in 2014.

More than 250 professionals are dedicated to R&D.

Almirall has two R&D Centres of Excellence in Europe.

Almirall has over 260 qualified professionals working in R&D in two centres in Spain and Germany.

R&D Centre of Excellence in Sant Feliu de Llobregat (Barcelona, Spain) Almirall headquarters flagship R&D

Centre Almirall carries out most of its R&D activities at its facility in Sant Feliu de Llobregat (just outside Barcelona), which was opened in 2006. Our flagship R&D centre, with a surface area of over 27,500m2, is equipped with the most advanced technology and employs highly-qualified professionals who cover all disciplines involved in the process of conducting the research and development of a new drug. In addition to this centre, Almirall also has a chemical plant in Sant Andreu de la Barca (also in the Barcelona area). It supplies the active ingredients needed for toxicological, pre-clinical and clinical studies.

Almirall Centre of Excellence for Dermatology in Reinbek (Germany)

This centre, which was acquired by Almirall in 2007, is located on the outskirts of Hamburg and has a total surface area of 21,000m2. At this facility, Almirall experts work on development programmes to find new formulations for the treatment of skin diseases. Over 60 years of work in this field rank it as a leading dermatology centre in Europe.